Maternal superobesity and perinatal outcomes

Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
American journal of obstetrics and gynecology (Impact Factor: 3.97). 05/2012; 206(5):417.e1-6. DOI: 10.1016/j.ajog.2012.02.037
Source: PubMed

ABSTRACT The purpose of this study was to determine the effect of maternal superobesity (body mass index [BMI], ≥ 50 kg/m(2)) compared with morbid obesity (BMI, 40-49.9 kg/m(2)) or obesity (BMI, 30-39.9 kg/m(2)) on perinatal outcomes.
We conducted a retrospective cohort study of birth records that were linked to hospital discharge data for all liveborn singleton term infants who were born to obese Missouri residents from 2000-2006. We excluded major congenital anomalies and women with diabetes mellitus or chronic hypertension.
There were 64,272 births that met the study criteria, which included 1185 superobese mothers (1.8%). Superobese women were significantly more likely than obese women to have preeclampsia (adjusted relative risk [aRR], 1.7; 95% confidence interval [CI], 1.4-2.1), macrosomia (aRR, 1.8; 95% CI, 1.3-2.5), and cesarean delivery (aRR, 1.8; 95% CI, 1.5-2.1). Almost one-half of all superobese women (49.1%) delivered by cesarean section, and 33.8% of superobese nulliparous women underwent scheduled primary cesarean delivery.
Women with a BMI of ≥ 50 kg/m(2) are at significantly increased risk for perinatal complications compared with obese women with a lower BMI.

Download full-text


Available from: Donna R Halloran, Jul 05, 2015
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To investigate pregnancy outcomes, particularly cesarean delivery (CD), among women with "isolated" obesity (i.e. without additional comorbidities). Study design: We conducted a retrospective population-based study between the years 1988-2010. The pregnancy outcomes of obese (prepregnancy BMI ≥30 kg/m(2)) and nonobese patients were compared. Patients with chronic hypertension, pregestational diabetes mellitus, other preexisting chronic morbidities, multiple gestations, age above 40 years, grand multiparity (above 5 deliveries), lack of prenatal care, and following fertility treatments were excluded from the analysis. Stratified analyses, using multiple logistic regression models, were performed to control for confounders. Results: During the study period, a total of 173,628 deliveries met the inclusion criteria; 1605 (0.9%) occurred in patients with "isolated" obesity. Higher rates of CD were found among patients with "isolated" obesity (30.7% vs. 12.3%; odds ration [OR] = 3.2; p < 0.001). When controlling for possible confounders, using a multivariable model with CD as the outcome variable, the association between "isolated" obesity and CD remained significant (adjusted OR = 2.6; p < 0.001). No significant differences were found in the risks of perinatal complications including perinatal mortality, shoulder dystocia, congenital malformations, and low 5-min Apgar score. Conclusion: "Isolated" obesity, although not a risk factor for adverse perinatal outcomes, is an independent risk factor for CD.
    The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 08/2012; 25(12). DOI:10.3109/14767058.2012.716464 · 1.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The placenta is a fetal-maternal endocrine organ responsible for ensuring proper fetal development throughout pregnancy. Adverse insults to the intrauterine environment often lead to expression level changes in placental genes, many of which are epigenetically regulated by DNA methylation, histone modifications and ncRNA interference. These epigenetic alterations may cause placental dysfunction, resulting in offspring of low birthweight owing to adverse pregnancy complications such as intrauterine growth restriction. Numerous epidemiological studies have shown a strong correlation between low birthweight and increased risk of developing metabolic diseases and neurological imbalances in adulthood, and in subsequent generations, indicating that epigenetic regulation of gene expression can be propagated stably with long-term effects on health. This article provides an overview of the various environmental factors capable of inducing detrimental changes to the placental epigenome, as well as the corresponding mechanisms that prime the offspring for onset of disease later in life.
    Epigenomics 10/2012; 4(5):561-9. DOI:10.2217/epi.12.49 · 5.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The different screening and diagnostic methods for gestational diabetes currently in clinical use has led the NIH's Office of Disease Prevention to organize a consensus conference to better understand the potential ramifications of changing the current screening and diagnostic criteria in the United States versus keeping current practices in place. Research has demonstrated that even mild forms of hyperglycemia potentially pose significant adverse health consequences for pregnant women and their children. Thus, it is anticipated that lowering the diagnostic criteria for gestational diabetes will significantly reduce morbidity and healthcare costs in the long term. However, such a change would dramatically increase the number of women identified as having this disease and place a significantly greater burden on an already overburdened primary health care system. Although several cost-benefit analyses suggest that such a change will improve health outcomes for mothers and babies, at least one study found that these anticipated public health benefits will not occur unless a higher level of care is devoted to these newly diagnosed patients. There also is a distinct possibility that changing the diagnostic criteria for GDM will increase cesarean delivery rates, which might offset many of the public health gains engendered by diagnosing more women with this condition. The scientific dilemma to change or not to change, thus, requires a rigorous analysis of the scientific, economic, practice, and legal pros and cons to achieve a satisfactory answer.
    American journal of obstetrics and gynecology 10/2012; 208(4). DOI:10.1016/j.ajog.2012.10.887 · 3.97 Impact Factor